CDC's 2019 Antibiotic Resistance Threats Report: Clindamycin-resistant Group B Streptococcus

Details

• Corporate Authors:
  Centers for Disease Control and Prevention (U.S.) ; National Center for Emerging Zoonotic and Infectious Diseases (U.S.). Division of Healthcare Quality Promotion. Antibiotic Resistance Coordination and Strategy Unit .
• Description:
  Type: Bacteria
  
  Also known as: Resistant group B strep, GBS
  
  About: GBS can cause severe illness in people of all ages.
  
  Estimated drug-resistant infections in 2016: 13,000
  
  Estimated deaths in 2016: 720
  
  This fact sheet is part of CDC’s 2019 Antibiotic Resistance Threats Report.
  
  The full report, including data sources, is available at www.cdc.gov/DrugResistance/Biggest-Threats.html.
  
  CS298822-A
  
  Publication date from document properties.
  
  threats-report/gbs-508.pdf
  
  
• Subjects:
  Anti-Bacterial Agents Anti-Infective Agents Antimicrobial Stewardship Clindamycin Drug Resistance, Microbial Streptococcal Infections Streptogramin Group B
• Series:
  Antibiotic Resistance Threats Reports
• Document Type:
  Text
• Genre:
  Fact Sheet
• Place as Subject:
  United States
• Pages in Document:
  2 unnumbered pages
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha-512:3bd96d5bc16937503c2ae721b2d3b20e38a644b8de5baa57e8e12f25c4532c2e806293fed2d77295cd389820371509d92c29fe2dfc7ab80bd387f30480d9fee7
• Download URL:
  https://stacks.cdc.gov/view/cdc/83737/cdc_83737_DS1.pdf
• File Type:
  [PDF - 382.39 KB ]